FDA Inspection 1122448 — Amryt Pharmaceuticals, Inc.
The FDA completed an inspection of Amryt Pharmaceuticals, Inc. on Jan 23, 2020 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 23, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Boston, MA (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)